CoChat

DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma

Open access
Amodio, Nicola, Leotta, Marzia, Bellizzi, Dina, Di Martino, Maria Teresa, D’Aquila, Patrizia, Lionetti, Marta, Fabiani, Fernanda, Leone, Emanuela, Gullà, Anna Maria, Passarino, Giuseppe, Caraglia, Michele, Negrini, Massimo, Neri, Antonino, Giordano, Antonio, Tagliaferri, Pierosandro, Tassone, Pierfrancesco · 2012 · Oncotarget
Cited by 149

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

// Nicola Amodio 1 , Marzia Leotta 1 , Dina Bellizzi 2 , Maria Teresa Di Martino 1 , Patrizia D’Aquila 2 , Marta Lionetti 3 , Fernanda Fabiani 1 , Emanuela Leone 1 , Anna Maria Gullà 1 , Giuseppe Passarino 2 , Michele Caraglia 4 , Massimo Negrini 5 , Antonino Neri 3 , Antonio Giordano 6 , Pierosandro Tagliaferri 1 and Pierfrancesco Tassone 1,6 1 Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy 2 Department of Cell Biology, University of Calabria, Cosenza 3 Department of Medical Sciences University of Milan, Hematology 1, IRCCS Policlinico Foundation, Milan, Italy 4 Department of Biochemistry and Biophysics, Second University of Naples, Naples, Italy 5 Department of Experimental Medicine and Diagnostics,University of Ferrara 6 Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA Correspondence: Pierfrancesco Tassone, email: // Keywords : miR-29b, microRNA, multiple myeloma, DNA methyltransferases, DNMT Received : September 21, 2012, Accepted : October 19, 2012, Published : October 21, 2012 Abstract Aberrant DNA methylation plays a relevant role in multiple myeloma (MM) pathogenesis. MicroRNAs (miRNAs) are a class of small non-coding RNAs that recently emerged as master regulator of gene expression by targeting protein-coding mRNAs. However, miRNAs involvement in the regulation of the epigenetic machinery and their potential use as therapeutics in MM remain to be investigated. Here, we provide evidence that the expression of de novo DNA methyltransferases (DNMTs) is deregulated in MM cells. Moreover, we show that miR-29b targets DNMT3A and DNMT3B mRNAs and reduces global DNA methylation in MM cells. In vitro transfection of MM cells with synthetic miR-29b mimics significantly impairs cell cycle progression and also potentiates the growth-inhibitory effects induced by the demethylating agent 5-azacitidine. Most importantly, in vivo intratumor or systemic delivery of synthetic miR-29b mimics, in two clinically relevant murine models of human MM, including the SCID-synth-hu system, induces significant anti-tumor effects. All together, our findings demonstrate that aberrant DNMTs expression is efficiently modulated by tumor suppressive synthetic miR-29b mimics, indicating that methyloma modulation is a novel matter of investigation in miRNA-based therapy of MM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.675

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Amodio, N., Leotta, M., Bellizzi, D., Di Martino, M. T., D’Aquila, P., Lionetti, M., Fabiani, F., Leone, E., Gullà, A. M., Passarino, G., Caraglia, M., Negrini, M., Neri, A., Giordano, A., Tagliaferri, P., & Tassone, P.
Venue
Oncotarget
Published
2012-10-21
Volume
3
Issue
10
Pages
1246-1258
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1786491527
Cited by
149
References
7
FWCI
5.94
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.